1125 related articles for article (PubMed ID: 25550231)
1. Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.
Singewald N; Schmuckermair C; Whittle N; Holmes A; Ressler KJ
Pharmacol Ther; 2015 May; 149():150-90. PubMed ID: 25550231
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibitors as cognitive enhancers in fear, anxiety and trauma therapy: where do we stand?
Whittle N; Singewald N
Biochem Soc Trans; 2014 Apr; 42(2):569-81. PubMed ID: 24646280
[TBL] [Abstract][Full Text] [Related]
3. Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches.
Sartori SB; Maurer V; Murphy C; Schmuckermair C; Muigg P; Neumann ID; Whittle N; Singewald N
Int J Neuropsychopharmacol; 2016 Jun; 19(6):. PubMed ID: 26625894
[TBL] [Abstract][Full Text] [Related]
4. The use of cognitive enhancers in animal models of fear extinction.
Kaplan GB; Moore KA
Pharmacol Biochem Behav; 2011 Aug; 99(2):217-28. PubMed ID: 21256147
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice.
Zhang G; Ásgeirsdóttir HN; Cohen SJ; Munchow AH; Barrera MP; Stackman RW
Neuropharmacology; 2013 Jan; 64(1):403-13. PubMed ID: 22722027
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological intervention of conditioned fear and its extinction].
Huang R; Li Z; Chen H; Huang Y; Ding L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):968-72. PubMed ID: 23000774
[TBL] [Abstract][Full Text] [Related]
7. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
8. Post-exposure cortisol administration does not augment the success of exposure therapy: A randomized placebo-controlled study.
Raeder F; Merz CJ; Tegenthoff M; Wolf OT; Margraf J; Zlomuzica A
Psychoneuroendocrinology; 2019 Jan; 99():174-182. PubMed ID: 30245330
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of the infralimbic and prelimbic areas of the prefrontal cortex in reconsolidation of a traumatic memory.
Levin N; Kritman M; Maroun M; Akirav I
Eur Neuropsychopharmacol; 2017 Sep; 27(9):900-912. PubMed ID: 28647452
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid but not D-cycloserine facilitates sleep-dependent offline learning of extinction and habituation of conditioned fear in humans.
Kuriyama K; Honma M; Yoshiike T; Kim Y
Neuropharmacology; 2013 Jan; 64():424-31. PubMed ID: 22992332
[TBL] [Abstract][Full Text] [Related]
11. Enhancing dopaminergic signaling and histone acetylation promotes long-term rescue of deficient fear extinction.
Whittle N; Maurer V; Murphy C; Rainer J; Bindreither D; Hauschild M; Scharinger A; Oberhauser M; Keil T; Brehm C; Valovka T; Striessnig J; Singewald N
Transl Psychiatry; 2016 Dec; 6(12):e974. PubMed ID: 27922638
[TBL] [Abstract][Full Text] [Related]
12. Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model.
Whittle N; Schmuckermair C; Gunduz Cinar O; Hauschild M; Ferraguti F; Holmes A; Singewald N
Neuropharmacology; 2013 Jan; 64(4):414-23. PubMed ID: 22722028
[TBL] [Abstract][Full Text] [Related]
13. L-DOPA improves extinction memory retrieval after successful fear extinction.
Gerlicher AMV; Tüscher O; Kalisch R
Psychopharmacology (Berl); 2019 Dec; 236(12):3401-3412. PubMed ID: 31243481
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of Evidence-Based Psychotherapy for PTSD With Cognitive Enhancers.
Marin MF; Lonak SF; Milad MR
Curr Psychiatry Rep; 2015 Jun; 17(6):39. PubMed ID: 25894356
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
16. Facilitation of fear extinction by the 5-HT(1A) receptor agonist tandospirone: possible involvement of dopaminergic modulation.
Saito Y; Matsumoto M; Yanagawa Y; Hiraide S; Inoue S; Kubo Y; Shimamura K; Togashi H
Synapse; 2013 Apr; 67(4):161-70. PubMed ID: 23152167
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.
Choi DC; Rothbaum BO; Gerardi M; Ressler KJ
Curr Top Behav Neurosci; 2010; 2():279-99. PubMed ID: 21309114
[TBL] [Abstract][Full Text] [Related]
18. Limbic Neuropeptidergic Modulators of Emotion and Their Therapeutic Potential for Anxiety and Post-Traumatic Stress Disorder.
Marvar PJ; Andero R; Hurlemann R; Lago TR; Zelikowsky M; Dabrowska J
J Neurosci; 2021 Feb; 41(5):901-910. PubMed ID: 33472824
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Fear Extinction: Pharmacological Approaches.
Ponomareva OY; Fenster RJ; Ressler KJ
Curr Top Behav Neurosci; 2023; 64():289-305. PubMed ID: 37584834
[TBL] [Abstract][Full Text] [Related]
20. Can fear extinction be enhanced? A review of pharmacological and behavioral findings.
Fitzgerald PJ; Seemann JR; Maren S
Brain Res Bull; 2014 Jun; 105():46-60. PubMed ID: 24374101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
